SSC
SEM

Syverson Strege & Co’s Select Medical SEM Stock Holding History

Syverson Strege & Co’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,409
Closed -$89.3K – 515
2023
Q1 		$89.3K Sell
6,409
-2,747
-30% -$40.4K 0.04% 97
2022
Q4 		$122K Buy
+9,156
New +$118K 0.06% 81

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Syverson Strege & Co's SEM Position: Q2 2023 in Review

Syverson Strege & Co sold out of Select Medical (SEM) in Q2 2023, closing a stake of 6,409 shares — an estimated $89.3K sold.

Syverson Strege & Co first reported a position in SEM in Q4 2022 and held it in 2 quarters. The position peaked at $122K in Q4 2022. 226 funds tracked by Wall St. Rank hold SEM as of Q2 2023.

  • Syverson Strege & Co reported no remaining Select Medical position as of Q2 2023 after selling out during the quarter.
  • Syverson Strege & Co sold 6,409 Select Medical shares in Q2 2023, an estimated $89.3K.
  • Syverson Strege & Co first reported a position in Select Medical in Q4 2022 and held it in 2 quarters.
  • Syverson Strege & Co's Select Medical position peaked at $122K in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Select Medical as of Q2 2023.

Based on Syverson Strege & Co's 13F filing for Q2 2023, filed 4 Aug 2023.